NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 262 filers reported holding NEOGENOMICS INC in Q4 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,290,512 | -20.9% | 2,706,214 | +3.4% | 0.00% | -20.0% |
| Q2 2023 | $42,062,255 | -4.0% | 2,617,439 | +4.0% | 0.01% | -16.7% |
| Q1 2023 | $43,836,146 | +196854.4% | 2,517,871 | +4.5% | 0.01% | +100.0% |
| Q4 2022 | $22,257 | -99.9% | 2,408,779 | +2.5% | 0.00% | 0.0% |
| Q3 2022 | $20,229,000 | +10.4% | 2,349,513 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $18,316,000 | -26.5% | 2,247,396 | +9.6% | 0.00% | 0.0% |
| Q1 2022 | $24,921,000 | -64.4% | 2,051,162 | -0.0% | 0.00% | -62.5% |
| Q4 2021 | $70,001,000 | -28.8% | 2,051,612 | +0.6% | 0.01% | -38.5% |
| Q3 2021 | $98,348,000 | +8.0% | 2,038,725 | +1.2% | 0.01% | 0.0% |
| Q2 2021 | $91,031,000 | -1.5% | 2,015,304 | +5.1% | 0.01% | -7.1% |
| Q1 2021 | $92,451,000 | +1.7% | 1,916,897 | +13.5% | 0.01% | -6.7% |
| Q4 2020 | $90,939,000 | +54.6% | 1,689,077 | +5.9% | 0.02% | +25.0% |
| Q3 2020 | $58,840,000 | +17.0% | 1,595,025 | -1.8% | 0.01% | +9.1% |
| Q2 2020 | $50,301,000 | +21.3% | 1,623,673 | +8.1% | 0.01% | 0.0% |
| Q1 2020 | $41,453,000 | -49.9% | 1,501,440 | -46.9% | 0.01% | +22.2% |
| Q4 2019 | $82,666,000 | +216.9% | 2,826,222 | +107.1% | 0.01% | +50.0% |
| Q3 2019 | $26,087,000 | -8.4% | 1,364,430 | +5.1% | 0.01% | -14.3% |
| Q2 2019 | $28,479,000 | +24.5% | 1,298,079 | +16.1% | 0.01% | +16.7% |
| Q1 2019 | $22,882,000 | -7.1% | 1,118,400 | -42.8% | 0.01% | +50.0% |
| Q4 2018 | $24,640,000 | +110.9% | 1,954,178 | +156.7% | 0.00% | +33.3% |
| Q3 2018 | $11,686,000 | +48.7% | 761,363 | +27.0% | 0.00% | +50.0% |
| Q2 2018 | $7,858,000 | +76.1% | 599,446 | +9.6% | 0.00% | +100.0% |
| Q1 2018 | $4,463,000 | -1.7% | 547,029 | +6.8% | 0.00% | -50.0% |
| Q4 2017 | $4,538,000 | -15.9% | 512,281 | +5.7% | 0.00% | 0.0% |
| Q3 2017 | $5,396,000 | +32.1% | 484,852 | +6.3% | 0.00% | 0.0% |
| Q2 2017 | $4,085,000 | +23.3% | 456,024 | +8.6% | 0.00% | +100.0% |
| Q1 2017 | $3,313,000 | -4.3% | 419,958 | +3.9% | 0.00% | -50.0% |
| Q4 2016 | $3,462,000 | +8.1% | 404,116 | +3.7% | 0.00% | 0.0% |
| Q3 2016 | $3,203,000 | +2.6% | 389,711 | +0.4% | 0.00% | 0.0% |
| Q2 2016 | $3,121,000 | +30.4% | 388,286 | +9.3% | 0.00% | +100.0% |
| Q1 2016 | $2,393,000 | -11.1% | 355,158 | +3.8% | 0.00% | -50.0% |
| Q4 2015 | $2,691,000 | +50.0% | 342,106 | +9.2% | 0.00% | +100.0% |
| Q3 2015 | $1,794,000 | +18.3% | 313,181 | +11.7% | 0.00% | 0.0% |
| Q2 2015 | $1,516,000 | +34.6% | 280,332 | +16.2% | 0.00% | 0.0% |
| Q1 2015 | $1,126,000 | +15.7% | 241,207 | +3.4% | 0.00% | 0.0% |
| Q4 2014 | $973,000 | -19.8% | 233,356 | +0.2% | 0.00% | 0.0% |
| Q3 2014 | $1,213,000 | +125.9% | 232,822 | +43.9% | 0.00% | – |
| Q2 2014 | $537,000 | -15.0% | 161,838 | -11.3% | 0.00% | – |
| Q1 2014 | $632,000 | +29.0% | 182,370 | +34.5% | 0.00% | – |
| Q4 2013 | $490,000 | +23.1% | 135,596 | +2.2% | 0.00% | – |
| Q3 2013 | $398,000 | -22.4% | 132,653 | +2.8% | 0.00% | – |
| Q2 2013 | $513,000 | – | 128,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |